Douglas C. Anthony, MD, Duke University, PhD, Duke University

Affiliations: 
2011- Pathology and Laboratory Medicine Brown University, Providence, RI 
Area:
Functional neuroanatomy Neuropathology, brain tumors Peripheral neuropathy, neuromuscular disease Myopathies Neurotoxicology Neurofilaments, and neuronal cytoskeleton
Website:
https://vivo.brown.edu/display/dca
Google:
"Douglas Anthony"
Bio:

Dr. Anthony is a Professor of Pathology and Laboratory Medicine, and Professor of Neurology, at the Warren Alpert School of Medicine at Brown University. He received his B.S. in Chemical Engineering from Washington University in St. Louis, and his M.D. and Ph.D. in Experimental Pathology from Duke University. He is board-certified in anatomic pathology and neuropathology, and studies the cellular and molecular basis of disorders that affect the nervous system. His work has been funded by the NIH, NSF, and private foundations, and he has served as a consultant to the National Institutes of Health, Environmental Protection Agency, National Board of Medical Examiners, U.S. Department of Justice, and a number of universities and foundations.
Prior academic appointments:
Assistant Professor of Pathology, Duke University
Associate Professor of Pathology, Harvard University
Professor and Chair of Pathology and Anatomy, and Professor of Neurology, University of Missouri

Mean distance: 106866
 
Cross-listing: Neuropathology Tree

Parents

Sign in to add mentor
Doyle G. Graham grad student 1980-1986
Peter C. Burger post-doc 1984-1987 Johns Hopkins
F. Stephen Vogel post-doc 1984-1987 Duke
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sudoh Y, Desai SP, Haderer AE, et al. (2004) Neurologic and histopathologic evaluation after high-volume intrathecal amitriptyline. Regional Anesthesia and Pain Medicine. 29: 434-40
Komori T, Scheithauer BW, Anthony DC, et al. (1998) Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm. The American Journal of Surgical Pathology. 22: 1171-83
Wang GK, Vladimirov M, Shi H, et al. (1998) Structure-activity relation of N-alkyl tetracaine derivatives as neurolytic agents for sciatic nerve lesions. Anesthesiology. 88: 417-28
Wang GK, Vladimirov M, Quan C, et al. (1996) N-butyl tetracaine as a neurolytic agent for ultralong sciatic nerve block. Anesthesiology. 85: 1386-94
Graham DG, Amarnath V, Valentine WM, et al. (1995) Pathogenetic studies of hexane and carbon disulfide neurotoxicity. Critical Reviews in Toxicology. 25: 91-112
Denlinger RH, Anthony DC, Amarnath K, et al. (1994) Metabolism of 3,3'-iminodipropionitrile and deuterium-substituted analogs: potential mechanisms of detoxification and activation. Toxicology and Applied Pharmacology. 124: 59-66
Pyle SJ, Graham DG, Anthony DC. (1994) Dimethylhexanedione impairs the movement of neurofilament protein subunits, NFM and NFL, in the optic system. Neurotoxicology. 15: 279-86
Valentine WM, Graham DG, Anthony DC. (1993) Covalent cross-linking of erythrocyte spectrin by carbon disulfide in vivo. Toxicology and Applied Pharmacology. 121: 71-7
Pyle SJ, Amarnath V, Graham DG, et al. (1993) Decreased levels of the high molecular weight subunit of neurofilaments and accelerated neurofilament transport during the recovery phase of 2,5-hexanedione exposure. Cell Motility and the Cytoskeleton. 26: 133-43
Thomas LO, Boyko OB, Anthony DC, et al. (1993) MR detection of brain iron. Ajnr. American Journal of Neuroradiology. 14: 1043-8
See more...